Integrins, Matrix, Etc.

Kidney International (1992) 41, 671–678; doi:10.1038/ki.1992.103

Proteinases and glomerular matrix turnover

Malcolm Davies, John Martin, Gareth J Thomas and David H Lovett

1Institute of Nephrology, University of Wales College of Medicine, Royal Infirmary, Cardiff, Wales, United Kingdom and V.A. Medical Center, University of California, San Francisco, California, USA

Correspondence: Dr Malcolm Davies, Institute of Nephrology, University of Wales College of Medicine, Royal Infirmary, Cardiff, CF2 1SZ Wales, United Kingdom.

Top

Abstract

The mesangial cell is surrounded by a pericellular matrix (MM), the composition of which helps to determine the physical, mechanical and functional properties of the glomerulus. This highly specialized matrix, like the glomerular basement membrane (GBM), is composed mainly of type IV collagen, laminin and heparan sulphate proteoglycan. In addition, and in contrast to the GBM, the MM also contains significant amounts of fibronectin and chrondroitin sulphate proteoglycan. Under normal physiological conditions these matrix components, as with the components of other connective tissues, are continually being synthesized and degraded, albeit at different rates. In the healthy glomerulus the controlled activity of the mesangial cell is thought to account for both MM synthesis and degradation, and furthermore is involved in the remodelling of the GBM. These processes appear to be tightly regulated since the integrity of both glomerular matrices are strictly maintained in the adult animal. Uncontrolled metabolism of the MM and GBM, however, does occur and a common feature in most forms of chronic renal disease is the development of sclerosis which is particularly marked within the mesangial space. This suggests that in the mesangial cell the mechanisms responsible for the turnover of matrix are no longer coordinated.

Current views suggest that degradation of the extracellular matrix (ECM) is a two step process with initial enzymatic or physical disruption (such as, oxygen radical damage) in the extracellular space followed by endocytosis of the partially degraded components and subsequent digestion by lysosomal proteinases such as cathepsins B, L and D. The serine and the metalloproteinases are most likely to play a critical role in the first stage since they are active at neutral pH and are secreted by cells at the appropriate site. This review summarizes the biochemical properties of tissue proteinases, with particular emphasis on the recent advances of the functional properties and control of the matrix neutral metalloproteinases (MMPs), and indicates their involvement in renal pathology. Since this review is brief and somewhat arbitrarily selective, only recent key papers and reviews are included.

Top

References

  1. Baricos WH, Shah SV: Proteinases in renal disease. Kidney Int 40:161–173 | PubMed | ISI | ChemPort |
  2. Boone TC, Johnson MJ, De Clerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87:2800–2804, 1990 | Article | PubMed | ChemPort |
  3. Collier IE, Burns GAP, Goldberg GI, Gerhard DS: On the structure and chromosome location of the 72- and 95-kDa human IV collagenase genes. Genomics 9:429–434, 1991 | Article | PubMed | ISI | ChemPort |
  4. Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Bire-Dal-Hansen H, Van Wart HE: Proteolytic activities of human fibroblast collagenase: Hydrolysis of a broad range of substrates at a single site. Biochemistry 29:6670–6677, 1990
  5. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600–6605, 1989
  6. Hasty AK, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL: Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265:11421–11424, 1990
  7. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632–2636, 1989 | Article | PubMed | ChemPort |
  8. Lyons JG, Birkedal-Hansen B, Moore WGI, O'Grady RL, Birkedal-Hensen H: Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry 30:1449–1456, 1991
  9. Mackay AR, Hartzler JL, Pelina MD, Thorgeirsson UP: Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J Biol Chem 265:21929–21934, 1990 | PubMed | ISI | ChemPort |
  10. Martin J, Davies M, Thomas GJ, Lovett DL: The control of glomerular matrix turnover: The characterization of a neutral proteinase and its specific inhibitor secreted by human mesangial cells. Kidney Int 36:790–801, 1989 | PubMed | ISI | ChemPort |
  11. Murphy G, Docherty AJP, Hembry RM, Reynolds JJ: Metalloproteinases and tissue damage. Brit J Rheumatol 30(Suppl 1):25–31, 1991
  12. Overall CM, Wrana JL, Sodek J: Independant regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860–1869, 1989 | PubMed | ISI | ChemPort |
  13. Quantain B, Murphy G, Breathnach R: Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28:5327–5334, 1991
  14. Springman EB, Angleton EL, Birkedale-Hansen H, Van Wart H: Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87:364–368, 1990 | PubMed | ChemPort |
  15. Werb Z, Hembry RM, Murphy G, Aggeler J: Commitment to expression of the metalloproteinases, collagenase and stromelysin: Relationship to inducing events to change in cytoskeletal architecture. J Cell Biol 102:689–702, 1986

Extra navigation

.
ADVERTISEMENT